Repeated COVID-19 relapse during post- discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2

A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavirinterferon a2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance. Copyright (c) 2020, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Automated summary

This case study revealed a prolonged viral shedding time of 67 days, with COVID-19 relapse attributed to inconsistent chest radiography and SARS-CoV-2-RNA detection post-discharge. Lopinavirinterferon a2b boosted ribavirin with subsequent lopinavir boosted budesonide may be an effective treatment for viral clearance.